Mounjaro Explained: How It Differs From Other Weight Loss Medications

Mounjaro, also known as tirzepatide, is a newer weight loss medication that has gained significant attention due to its strong results in clinical trials. Like other modern treatments, it works by targeting the biological systems that regulate appetite and metabolism.

If you are exploring weight loss medication options, understanding how Mounjaro works and how it compares to alternatives such as Wegovy can help you make a more informed decision. For a broader overview, see our guide How Weight Loss Medications Work: A Medical Overview.

What is Mounjaro and how does it work
Mounjaro contains tirzepatide, a medication that acts on two hormone pathways: GLP-1 and GIP. These hormones play a role in appetite regulation, fullness, and blood sugar control.

By targeting both pathways, Mounjaro may enhance feelings of fullness, reduce appetite, and improve how the body processes energy. If you would like a deeper understanding of GLP-1 based treatments, see our article What Are GLP-1 Medications and Why Do They Help With Weight Loss.

How Mounjaro differs from Wegovy
Wegovy (semaglutide) works on the GLP-1 pathway alone, while Mounjaro works on both GLP-1 and GIP receptors. This dual mechanism may lead to differences in appetite control and metabolic response.

Clinical studies suggest that some individuals may experience greater average weight loss with tirzepatide, although individual responses vary. We will explore this in more detail in our upcoming comparison article on Wegovy and Mounjaro.

Who Mounjaro may be suitable for
Mounjaro may be considered for adults with a higher body weight where lifestyle changes alone have not been sufficient. As with all prescription treatments, suitability depends on a full medical assessment, including BMI, medical history, and any existing health conditions.

What to expect when starting Mounjaro
Mounjaro is taken as a weekly injection. Treatment begins at a lower dose and is increased gradually over time. This helps reduce side effects and allows the body to adapt.

Many people notice a reduction in appetite within the first few weeks. Weight loss tends to occur progressively over several months.

Common side effects
The most common side effects are similar to other medications in this group and include nausea, vomiting, diarrhoea, constipation, and reduced appetite.

These effects are usually temporary and can often be managed with gradual dose increases and appropriate dietary adjustments. We will explore this further in our guide to managing side effects of weight loss medication.

Emerging treatments and future developments
Mounjaro represents a step forward in weight loss treatment, but research continues to evolve. New medications such as retatrutide are being studied and may offer additional options in the future, although they are not yet approved for routine use in the UK.

Access and cost in the UK
Mounjaro may be available through specialist services or private providers. Availability and prescribing criteria can vary, and treatment should always include appropriate clinical supervision.

Medication as part of a wider plan
As with other treatments, Mounjaro works best when combined with supportive lifestyle changes. Nutrition, physical activity, sleep, and stress management all play an important role in long term success.

For a complete overview of how medication fits into weight management, see our pillar guide Weight Loss Medication in the UK: A Patient-Centred Pillar Guide.

Further reading
• NICE guidance on obesity management
• NHS weight management services
• Clinical research on tirzepatide